Sign in

NCT05332457Recruiting

The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation

The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation: a Crossover Randomized Controlled Trial.

Source: ClinicalTrials.gov · Last updated 24 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a prospective study to evaluate changes in exercise capacity and chronotropic response to exercise before and after beta-blocker dosage reduction in patients with atrial fibrillation (AF).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
10 Apr 2022
Start date
1 Jul 2025
Primary completion date
31 Jul 2025
Lead sponsor
National Taiwan University Hospital
NCT number
NCT05332457

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Jul 2025 to the primary completion date, 31 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Beta-blocker usage due to indications other than rate control for atrial fibrillation.
  • Inability to perform a cardiopulmonary exercise testing.
  • Presence of contraindications for cardiopulmonary exercise testing according to the American College of Sports Medicine's Guidelines for Exercise Testing and Prescription.
  • Patients with implantable cardioverter defibrillator or pacemaker.
  • Pregnancy.
  • Inability to provide informed consent.

Who the study is looking for

  • \> 20 years of age.
  • Clinically stable patients with persistent atrial fibrillation using beta-blocker as rate-control agent without dosage adjustment for at least 3 months.
  • Resting heart rate \< 80 bpm.
  • Left ventricular ejection fraction \> 50%.

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.